Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹-7.88 Cr₹3.66 Cr₹11 Cr₹15 Cr₹14 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA is ₹-7.88 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹-7.88 Cr
Mar2025₹3.66 Cr
Mar2024₹11 Cr
Mar2023₹15 Cr
Mar2022₹14 Cr

How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹-7.88 Cr
Negative
Mar2025 ₹3.66 Cr
-65.52
Mar2024 ₹11 Cr
-30.98
Mar2023 ₹15 Cr
11.78
Mar2022 ₹14 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,897.4 Cr 3.4% -10.6% 78.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

3.4%

-10.6%

78.1%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses